Section Review; Anti-infectives: Review of actinomycetes compounds 1990 – 1995

References

• WORLD CONSERVATION MONITORING CENTER. GLOBAL I3IODIVERSITY: Status of the Earth's Living Resources. Chap-man and Hall, London (1992).
   Google Scholar
• I IODGSON J: Pharmaceutical screening: from off-the-wall to off-the-shelf. Biotechnology (1993) 11:683–688.
   PubMedGoogle Scholar
• YAR13ROUGH GG, TAYLOR DP, ROWLANDS RT, CRAW-FORD MS, LASURE LL: Screening microbial metabolites for new drugs: theoretical and practical issues. J. Anti-biot. (1993) 46:535–544.
   PubMed Web of Science ®Google Scholar
• TIIOMSON RH: The Chemistry of Natural Products. Blackie Academic & Professional, London (1993).
   Google Scholar
• SANGLIER JJ, HAAG H, I rucK TA, FEHR T: Novel bioactive compounds from Actinomycetes: a short review (1988-1992). Res. Microbiol. (1993) 144:633–642.
   PubMed Web of Science ®Google Scholar
• JENSEN, FENICAL W: Strategies for the discovery of secondary metabolites from marine bacteria: ecological perspectives. Ann. Rev. Micro biol. (1994) 48:559–584.
   PubMed Web of Science ®Google Scholar
• TRISCHMAN J, TAPIOLAS DM, FENICAL W, DWIGHT R,JENSEN PR et al.: Salinamide A and antiinflammatory depsipeptides from a marine streptomycete J. Am. Chem. Soc. (1994) 116:757–758.
   Google Scholar
• FISH DN, PISCITELLI SC, DANZIGER LH: Development ofresistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmcotherapy (1995) 15:279–291.
   PubMed Web of Science ®Google Scholar
• TENOVER FC: The best of times, the worst of times.Pharma. World Sci. (1995) 17:149–151
   PubMed Web of Science ®Google Scholar
• ISAACSON RE: Novel targets for antibiotics. Exp. Opin. Invest. Drugs (1994) 3:83–91.
   Google Scholar
• KADAM S: Mechanism-based screens in the discovery of chemotherapeutic antibacterials. Biotechnology (1994) 26:247–266.
   PubMedGoogle Scholar
• FLEISCHMANN RD, ADAMS MD, WHITE 0, CLAYTON RA, KIRKNESS EF, KERLAVAGE AR, BLIT CJ et al.: Whole-genome random sequencing and assembly of Haerno- philus influenzae Rd. Science (1995) 269:496–498.
   Google Scholar
• MORISHITA A, ISHIZAWA K, MUT01-1 N, YAMAMOTO T,HAYASHI M, YAGINUMA S: Sporeamicin A, a new macrolide antibiotic II. Structure determination J. An-tibia (1992) 45:607–612.
   Google Scholar
• YAGINUMA S, MORISHITA A, ISIIIZAWA K, MUROFUSIII 5, I IAYASHI M, MUTOII N: Sporeamicin A, a new macrolide antibiotic. I. Taxonomy, fermentation, isolation and characterization. j. Antibiot. (1992) 45:599–606
   Google Scholar
• MORISHITA A, MUTOH A. ISHIZAWA K, SUZUKI T, YOK-OIYAMA S, YAGINUMA 5: Sporeamicin A, a new macrolide antibiotic. 111. Biological properties. J. Anti-biol. (1992) 45:613–617.
   Google Scholar
• SAFE AF, WARREN B, CORFIELD A. MCNLILTY CA, WAT-SON B, MOUNTFORD RA, READ A. Helicobacter pylori infection in elderly people: correlation between histol-ogy and serology. Age and Ageing (1993) 22:215–216.
   Google Scholar
• KOHLRAUSCH 11, 110ELTJE JV: Analysis of murein and murein precursors during antibiotic induced lysis of Escherchia coll. .1, Bacteria (1991) 173:3425–3431.
   Google Scholar
• TOMITA K, NISHITO M, SMTOH K, YAMAMOTO H, I IOSHINO Y, OHKUMA H, KONISHI M, MIYAKI T, OKI T: Pradimicins A, B and C: new antifungal antibiotics. L Taxonomy, production, isolation and physicio-chemi-cal properties. J. Antibiot. (1990) 43:755–762.
   Google Scholar
• OKI T, TENMYO 0, HIRANO M, TOMATSU K, KAMEI H:Pradimicins A, B and C: new antifungal antibiotics. IL In vitro and in vivo biological activities. J. Antibiot. (1990) 43:763–770.
   PubMed Web of Science ®Google Scholar
• HEDGE VR, PATEL MG, GULLO VP, FUAR MS: Macrolac-tams: a new class of antifungal agents. J. Am. Chem. Soc. (1991) 112:6403–6405.
   Web of Science ®Google Scholar
• HEDGE VR, PATEL MG, HORAN A, GULLO VP, MARQUEZ F, GUNNARSON I, GENTILE F, LOEBENBERG D, KING A: Macrolactams: a novel class of antifungal antibiotics produced by Actinomadura spp. ScCC1776 and ScCC1777. J. Antibiot. (1992) 45:624–632.
   Google Scholar
• GREEN L, PETERSEN B, STEIMEL L, HAEBER P, CURRENT W: Rapid determination of antifungal activity by flow cytometry. J. Clin. Micro biol. (1994) 32:1088–1091.
   PubMed Web of Science ®Google Scholar
• TSUNAKAWA M, TENMYO 0, TOMITA K, NARUSE N, KOTAKE C, MIYAKI T, KONISHI M, OKI T: Quartrornicins, a complex of novel antiviral antibiotics. J. Antibiot. (1992) 45:180–188.
   PubMedGoogle Scholar
• TSUNAKAWA M, KOMIYAMA N, TENMYO 0, TOMITA K,KAWANO K, KOTAKE C, KONISHI M, OKI T: New antiviral antibiotics, cycloviracins B1 and B2. I. Production, Isolation, physico-chemical properties and biological activity. J. Antibiot. (1992) 45:1467–1471.
   Google Scholar
• OHTSUKA T, ITEZONO Y, NAKAYAMA N, KURANO M, NAKADA N, TANAKA H, SAWAIRI S, YOKOSE K: Structural elucidation of arthrobacillins A, B and C, structurally unique secondary metabolites of a microorganism. Tetrahedron Lett. (1992) 33:2705–2708.
   Web of Science ®Google Scholar
• ASANO T, MATSUOKA K, 'RDA T, KOBAYASHI M, KITA-MURA Y, HAYAKAWA T, IINUMA S, KAKINUMA A, KATO K: Novel retrovirus protease inhibitors, RPI-856 A, B, C and D, produced by Streptomyces sp. AL-322.J. Antibiot. (1994) 47:557–565.
   Google Scholar
• Enediyne Antibiotics as Antitumor Agents. Borders DB, Don-ald B, Doyle TW (Eds.), Marcel Dekker, Inc., New York (1995).
   Google Scholar
• KONISHI M, OIIKUMA H, MATSUMOTO K, SAITOH K, MIYAKI T. OKI T, KAWAGUCHI H: Dynemicins, new antibiotics with the 1,5-diyn-3-ene and anthraquinone subunit. I. Production, isolation and physico-chemical properties. J. Antibiot. (1991) 44:1300–1305.
   Google Scholar
• LEET JE, SCHROEDER DR, HOFSTEAD SJ, GOLIK J, COLSONKL, HUANG S, KLOI IR SE, DOYLE TW. MATSON JA: Kedar-cidin, a new chromoprotein antitumor antibiotic struc-ture elucidation of Kedarcin chromophore. J. Am. Chem. Soc. (1992) 114:7946–7948.
   Web of Science ®Google Scholar
• NICOLAOU KV, DAI WM, TSAY SC, ESTEVEZ VA, WRASIDO W: Designed enediynes: a new class of DNA-cleaving molecules with potent and selective anticancer activity. Science (1992) 256:1172–1178.
   PubMed Web of Science ®Google Scholar
• LANGLEY DR: Mechanism of action and molecular mod-eling of esperamicin Al, calichetnicin.gamaIl and dynemycin. In: Enediyne Antibiotics as Antitumor Agents. Borders DB, Donald B, Doyle TW (Eds.), Marcel Dekker, Inc., New York (1995):239–281.
   Google Scholar
• POVIS G: Signalling pathways as targets for anticancer drug development. Pharmac. Ther. (1994) 62: 57-9 5.
   Google Scholar
• UMEZAWA H: Screening of oncogene function inhibi-tors from microbial secondary metabolites. Studies in Natural Products Chemistry (1995) 15:439–463.
   Google Scholar
• GIBBS JB, OLIFF A, KOIIL NE: Farnesyttransferase inhibi- tors: Ras research yields a potential cancer therapeutic. Cell (1994) 77:175–178.
   PubMed Web of Science ®Google Scholar
• TAMANOI F: Inhibitors of Ras farnesyltransferase. Trends &ocher& Sci. (1993) 18:349–353.
   PubMed Web of Science ®Google Scholar
• HARA M, AKASAKA K, AKINAGA S, OKABE M, NAKANO H, GOMEZ R, WOOD D, LTH M, TAMANOI F: Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc. Natl. Acad. Sci. USA (1993) 90:2281–2285.
   PubMed Web of Science ®Google Scholar
• OMURA S, VAN DER PYL D, INOKOSHI J, TAKAHASHI Y, TAKESHIMA H: Peptkinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycetes. L Producing strain, fermentation, isolation and biologi-cal activity. J. Antibiot. (1993) 46:222–228.
   Google Scholar
• SILVERMAN KC, CASCALES C, GENILLOUD 0, SIGMUND JM, GARTNER SE, KOCK GE, GAGLIARDI MM, HEIMBUCH KB, NALLIN-OMSTEAD M, SANCHEZ M, DIEZ MT, MARTIN I, GARRITY GM, HIRSCH CF, GIBBS JB, SINGH SB, LING-HAM RB: Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase. Appl. Micro biol. Biotech-nol. (1995) 43:610–616.
   PubMed Web of Science ®Google Scholar
• LIU WC, BARBACID M, BULGAR M, CLARK JM, CROSSWELL AR, DEAB L, DOYLE TW, FERNANDES PB, HUANG 5, MANNE V, PIRNIK DM, WELLS JS, MEYERS E: 10 '-Des-methorrystreptonigrin, a novel analog of streptonigrin. J. Antibiot. (1992) 45:454–457.
   PubMedGoogle Scholar
• IMOTO M, UMEZAWA K, TAKAHASHI Y, NAGAWA H, IITAKA Y, NAKAMURA H, KOIZUM1Y, SASAKI Y, HAMADA M et at.: Isolation and structure determination of inostamycin a novel inhibitor of phosphatidylinositol turnover. J. Nat. Prod. (1990) 53:825–829.
   Google Scholar
• IMOTO M, TANIGUCHI Y, UMEZAWA K: Inhibition of CDP-DG inositol transferase activity by inostamycin. J. Biochem. (1992) 122:299–302.
   Google Scholar
• KAWADA M, IMOTO M, UMEZAWA K: Suppression of multidrug resistance by inostamycin in cultured human carcinoma KB-cells.]. Cell Pharmacol. (1991) 2:138–142.
   Google Scholar
• KAWADA M, SUMI S. UMEZAWA K, INOUYE 5, SAWA T, SETO Circumvention of multidrug resistance in hu-man carcinoma KB-cells by polyether antibiotics. J. Antibiot. (1992) 45:556–562.
   PubMed Web of Science ®Google Scholar
• NISHIOKA Fl, SAWA T, NAKAMURA II, IINUMA H, IKEDA D, SAWA R, NAGANAWA H, HAYASHI C, HAMADA M: Isolation and structure determination of novel phos-phatidylinositol kinase inhibitors Echiguanines A and B fromStreptomyces sp. J. Nat. Prod. (1991) 54:1321–1325.
   PubMed Web of Science ®Google Scholar
• OGAWARA II, I IIGASIII K, MANITA 5, HIDAKA M, KATO II, TAKENAWA T: An inhibitor of inositol-phospholipid-specific phospholipase C. Biochim. Biophys. Acta (1993) 1175289–292.
   Google Scholar
• AMEMIYA M, UENO M, OSONO M. MASUDA T. KINOSIIITA N. NISHIDA C, HAMADA M, ISHIZUKA M, TAKEUCHI T: Cytostatin, a novel inhibitor of cell adhesion to compo-nents of extracellular matrix produced by Streptomy-ces sp. MJ64-NF4. L Taxonomy, fermentation and biological activities. J. Antibiot. (1994) 47:536–540.
   Google Scholar
• AMEMIYA M, SOMENO T, SAWA R, NAGANAWA H, ISIIIZUKA M, TAKEUCHI T: Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ64-NF4. II. Physico-chemical properties and structure determination. J. Antibiot. (1994) 47:541–544.
   Google Scholar
• UENO M, AMEMIYA M, IIJAMA M, OSONO M, MASUDA T, KINOSHITA N, IKEDA T, IINUMA H, I IAMADA M, ISHIZUKA M, TAKEUCHI I: Delaminomycins, novel nonpeptide extracellular matrix receptor antagonists and a new class of potent inununomodulator. I. Taxonomy, fer-mentation, isolation and biological activity. J. Antibiot. (1993) 46:719–727.
   Google Scholar
• UENO M, AMEMIYA M, SOMENO T, MASUDA T, IINUMA H, NAGANAWA H, HAMADA M, ISHIZUKA M, TAKEUCHI T: IC101, extracellular matrix antagonist produced by Streptomyces sp. MJ202-72F3. Production, isolation, structure determination and biological activity. J Anti-biot. (1993) 46:1658–1665.
   Google Scholar
• ROWINSKY EE, CAZENAVE LA, DONEHOWER RC: Taxol a novel investigational antimicrotubule agent. J. Natl. Cancer Inst. (1990) 82:1247–1259.
   PubMed Web of Science ®Google Scholar
• STIERLE A, STROBEL G, STIERLE D, GROTHAUS P, BIG-NAMI G: The search for a taxol-producing microorgan-ism among the endophytic fungi of the Pacific yew, Taxus brevifolia. J. Nat. Prod. (1995) 58:1315–1324.
   PubMed Web of Science ®Google Scholar
• ARAI T, KAYAMA Y, SUENAGA T, HONDA H: Ascomycin, an antifungal antibiotic. J. Antibiot. (1962) 15:231–232.
   PubMed Web of Science ®Google Scholar
• KINO T, HATANAKA H, HASHIMOTO M, NISHIYAMA M, GOTO T, OKUHARA M, KOSHADA M, AOKI H, IMANAKA H: FK-506, a novel inarnunosuppressant isolated from a Streptomyces. L Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot. (1987) 40:1249–1255.
   Google Scholar
• SIGAL NE, DUMONT FJ: Cyclosporin A, FK-506 and rapatnycin: pharmacological probes of lymphocyte sig-nal transduction. Ann. Rev. Immunol. (1993) 10:519–560.
   Web of Science ®Google Scholar
• QUESNLAUX VF, BAUMANN G: Immunosuppressants. In:Immunochemistry. van Oss CJ, van Regenmortel HM (Eds.), Dekker, New York (1994):1017–1038.
   Google Scholar
• VAN DER WOLTDE, BIERER BE: Recent advances in im-munosuppression. Semin. Anesth. (1995) 14:85–92.
   Google Scholar
• SEFIGAL SN, BAKER II, VEZINA C: Raparnycin (Ay-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. (1975) 28:727–732.
   Google Scholar
• BROWN Ej, ALBERS MW, STUN TB, ICI IKAWA K. KEITI I CT,LANE WS, SCHREIBER SL: A mammalian protein targeted by Gl-arresting rapamycin-receptor complex. Nature (1994) 369:756–758.
   Google Scholar
• PRICE DJ, GROVE JR, CALVO V. AVRUCH J, BIERER BE: Rapamycin-induced inhibition of the 70 kilodalton S6 protein kinase. Science (1992) 257:973–976.
   Google Scholar
• BIERER BA: Cyclosporin A, FK506, and rapamycin: bind-ing to iramunophilins and biological action. Chem. Immunot. (1994) 59:128–155.
   PubMed Web of Science ®Google Scholar
• QUESNIAUX VF: Immunosuppressants: tools to investi-gate the physiological role of cytokines. BioEssays (1993) 15:731–739.
   PubMed Web of Science ®Google Scholar
• KUNT J, HALL MN: Cyclosporine A, FK506 and rapamy-cin: more than just immunosuppression. Trends Bio-chem. (1993) 18:334–338.
   PubMed Web of Science ®Google Scholar
• SANGLIER JJ: Im.munosuppressants from natural sources. In: Traditional Medicine. Mukherjee B (Ed.), Ox-ford and IBII Pub. Co., New Delhi (1993):125–176.
   Google Scholar
• SCHREIER MB, ZENKE G, BOREL JF, BAUMANN G: The continuous search for new ittununomodulators. Trans-plant. Proc. (1992) 24\(Suppl. 2):19–21.
   Google Scholar
• OKURA M, KINO T: Immunomodulators. In: The Discovery of Natural Products with Therapeutic Potential. Gullo VP (Ed.), Butterworth-Heinemann (1994):321–348.
   Google Scholar
• CRABTREE GR, CLIPSTONE NA: Signal transmission be-tween the plasma membrane and the nucleus of T lymphocytes. Ann. Rev. Biochem. (1994) 63:1045–1083.
   PubMed Web of Science ®Google Scholar
• BURRES NS, PREMACHANDRAN U, HOSLETON S, CWIK D, HOCHLOWSKI JE, YE Q, SUNGA GN etal.: Simple aromat-ics identified with a NFAT-lacZ transcription assay for the detection of immunosuppressants. J. Antibiot. (1995) 48:380–385.
   Google Scholar
• SALITURO GM, ZINK DL, DAHL A, NIELSEN J, WI) E, HUANG L, KASTNER C, DUMOND FJ: Meridamycin: a novel non-immunosuppressive FKBP12 ligand from Streptomyces bygroscoptus. Tetrahedron Lett. (1995) 36:997–1000.
   Google Scholar
• FEHR T, SANGLIER JJ, SCITULER W, GSCIIWIND L, PONELLE M, SCHILLING W, WIOLAND C: Antasomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Mt-cromonospora strain. J. Antibiot. (submitted).
   Google Scholar
• ISHIZUKA M, KAWATSU M, YAMASHITA T, UENO M, TAKEUCHI T: Low molecular weight itntnunomodula-tors produced by microorganisms. Int. J. Immunophar-macol. (1995) 17:133–139.
   PubMed Web of Science ®Google Scholar
• KUMAGAI H, MASUDA T, OHSONO M, HATTORI S, NA-GANAWA H, SAWA T, HAMADA M, ISGIZUKA M, TAKEUCHI T: Cytogenin, a novel antitumour substance. J. Antibiot. (1990) 30i: 1.505–1507.
   Google Scholar
• KUMAGAI H, OSONO M, SAKASHITA M, ISHIZUKA M, TAKEUCHI T: Action of cytogenin on lymphoid cells and their cytokine production.]. Antibiot. (1995) 48:317–320
   Google Scholar
• YAMASIIITA T, IIJIMA M, NAKAMURA H, ISSHIKI K, NA-GANAWA H, HATTORI 5, HAMADA M, ISHIKUZA M, TAKEUCHI, IITAKA Y: Conagenin, a low molecular weight isnmunomodulator produced by Streptomyces roseosporus. J. Antibiot. (1991) 44:557–559.
   PubMed Web of Science ®Google Scholar
• KAWATSU M. YAMASHITA T, OSONO M. ISHIZUKA M, TAKEUCHI T: T cell activation by conagenin in mice. Antibiot. (1993) 46:1687–1691.
   Google Scholar
• TAKIZAWA M, HIDA T, HORIGUCHI T, I IIRAMOTO A, HARDA S, TANIDA S: TAN-1511 A, B and C, microbial lipopeptides with G-CSF and GM-CSF inducing activity. J. Antibiot. (1995) 48:579–588.
   PubMed Web of Science ®Google Scholar
• IBANEZ CF, RYDEN M: Nerve growth factors in future therapies. Lakartidningen (1995) 92:2191–2194.
   PubMedGoogle Scholar
• MULLER IIW, JUNGHAUS U. KAPPLER J: Astroglial neurotrophic and neurite-promoting factors. Phar-maco. Ther. (1995) 65:1–18.
   Google Scholar
• OMURA S, FUJIMOTO T, OTOGURO K, MATSUZAKI K, MORIGUCHI R, TANAKA H, SASAKI Y: Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J. Antibiot. (1991) 44:113–116.
   PubMed Web of Science ®Google Scholar
• FENTEANY G, STANDAERT RF, REICIIARD GA, COREY EJ,SCHREII3ER SL: A beta-lactone related to lactacystin in-duces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA (1994) 92:3358–3362.
   Google Scholar
• COREY EJ, REICHARD GA, COREY EJ, CHOI S, SUNAZUKAT, NAGAMITSU T, MATSUZAKI K, TANAKA H, OMURA S et al.. Total synthesis of lactacystin. Chemtracts: Org. Chem. (1994) 7:266–272.
   Google Scholar
• NAGAMITSU T, SUNAZUKA T, STUMP H, OBATA R, ARIMA S, MATSUZAKI K, TANAKA H, OMURA S: Structure-activity relationships of lactacystin, the first non-protein neurotrophic factor. J. Antibiot. (1995) 48:747–748.
   PubMed Web of Science ®Google Scholar
• COYLE JT, PUTTFARCKEN P: Oxidative stress, glutamate and neurodegeneratice disorders. Science (1993) 262:689–695.
   PubMed Web of Science ®Google Scholar
• SHIN-YA K, TANAKA M, FURIHATA K, I-IAYAKAWA Y, SETOH: Structure of carquinostatin A, a new neuronal cell protecting substance produced by Streptomyces exfo-liatus. Tetrahedron Lett. (1993) 34:4943–4944.
   Web of Science ®Google Scholar
• DHIN-YA K, SHIMIZU S, KUNIGAMI T, FURIHATA K, FURI-HATA K, SETO H: A new neuronal cell protecting sub-stance, lavanduquinocin, produced by Streptomyces viridocbromogenes. J. Antibiot. (1995) 48:574–578.
   PubMed Web of Science ®Google Scholar
• TSURUMI Y, FUJIE K, NISHIKAWA K, KITYOTO S, OKUHARA M: Biological and pharmacological proper-ties of highly selectice new endothelin converting en-zyme inhibitor WS790898 isolated from Streptosporangium roseum No79089. J. Antibiot. (1995) 48:169–174.
   PubMed Web of Science ®Google Scholar
• LAM YK, WILLIAMS JRD, SIGMUND JM, SANCHEZ M, GENIL-LOUD 0, KONG YL, STEVENS-MILES S, HUANG L, GARRITY GM: Cochiniraicins, novel and potent cyclodepsipep-tide endothelin antagonists from a Microbispora sp. J. Antibiot. (1991) 45:1709–1716.
   Google Scholar
• LAM YK, HENSENS 0, HELMS G, WILLIAMS JRD, NALLIN M, SMITH, GARTNER S, HERRANZ RODRIGUEZ L, STEVENS-MILES S: L-755,805, anew polyketide endothelin binding inhibitor from an actinomycetes - purification charac-terization and structure determination. Tetrahedron Lett. (1995) 36:2013–2016.
   Google Scholar
• SHINDO K, YAMAGISHI Y, OKADA Y, KAWAI II: Collis-mycins A and B, novel non-steroidal inhibitors of dex-anaethasone glucocorticoid receptor binding. J. Antibiot. (1994) 47:1072–1074.
   PubMed Web of Science ®Google Scholar
• DIVEKAR PV, READ G, VINING LC: Caerulomycin, a new antibiotic from Streptomyces caeruleus Balacci. H. structure. Can. J. Chem. (1967) 45:1215–1223.
   Web of Science ®Google Scholar
• TSUCHIYA K, KOBAYASHI 5, KUROKAWA T, NAGAGAWA T. SI IIMADA N: Gualamycin, a novel acaricide produced by Streptomyces sp. NK11687.11. Structural elucidation. J. Antibiot. (1995) 48:630–634.
   Google Scholar
• TSUCHIYA K, KOBAYASHI S. HARADA T. KUROKAWA T, NAGAGAWA T, SI IIMADA N: Gualamycin, a novel acari-cide produced by Streptomyces sp. NK11687. I. Taxon- omy, production, isolation, and preliminary characeri-zatIon. J. Antibiot. (1995) 48:626–629.
   Google Scholar
• ISAAC BG, AYER SW, ELLIOTT RC, STONARD RJ: Herbox-idiene: a potent phytotoxic polyketide from Streptomy-ces sp. J. 01g. Chem. (1992) 57:7220–7226.
   Google Scholar
• MILLER-'WIDEMAN M, MAICKAR N, 'FRAN M, ISAAC B, BIEST N, STONARD R: Herboxidiene, a new herbicidal sub-stance from Streptomyces cbromofuscus A7847. J. An-tibiot. (1992) 45:914–921.
   PubMedGoogle Scholar
• SHIOMI K, HANEDA K, TOMODA H, IWAI Y, OMURA S: Cytosarolnomycins, new anticoccidial agents produced by Streptomyces sp. 1(0–8119.11. Structure elucidation of cytosaminomycins A, B, C and D. J. Antibiot. (1994) 47:782–786.
   Google Scholar
• HANEDA K, SHINOSE M, SEINO A, TABATA N, TOMODAH, 1WAI Y, OMURA S: Cytosaminomycins, new anticoc-cidial agents produced by Streptomyces sp. Ko-8119. I. Taxonomy, production, isolation and physico-chemi-cal and biological properties. J. Antibiot. (1994) 47:774–781.
   Google Scholar
• HAYAKAWA Y, HAWAKAMI K, SETO H: Structure of a newantibiotic, roseophilin. Tetrahedron Lett. (1992) 33:2701–2704.
   Web of Science ®Google Scholar
• SANGLIER JJ, \WHITEHEAD D, SADDLER GS, FERGUSON EV,GOODFELLOW M: Pyrolysis mass spectrometry as a method for the cLass ification and selection of Actinomy-cetes. Gene (1992) 115:235–242.
   PubMed Web of Science ®Google Scholar
• ANZAI Y, OKUDA T, WATANABE J: Application of therandom amplified polymorphic DNA using the polym-erase chain reaction for efficient elimination of dupli-cate strains in microbial screening. IL Actinomycetes. Antibiot. (1994) 47:183–193.
   Google Scholar